BRIEF published on 05/15/2024 at 18:20, 6 months 7 days ago O`KEY Group S.A. Announces Delisting of GDRs from London Stock Exchange London Stock Exchange Delisting Financial Markets O`KEY Group GDR
PRESS RELEASE published on 05/15/2024 at 18:15, 6 months 7 days ago O`KEY GROUP INTENDS TO DELIST ITS GDRs FROM LSE O'KEY Group S.A. announces intent to delist its GDRs from the London Stock Exchange, maintaining listings on MOEX and AIX. Last day on LSE set for 17 June 2024, effective 18 June 2024 London Stock Exchange O'KEY Group S.A. GDRs MOEX AIX
BRIEF published on 04/26/2024 at 16:05, 6 months 26 days ago O'KEY Group Reports Solid Revenue Growth in Q1 2024 Q1 2024 Results O'KEY Group Retail Revenue Growth DA! Discounters Expansion Russian Food Retail Market
PRESS RELEASE published on 04/26/2024 at 16:00, 6 months 26 days ago O`KEY GROUP REPORTS NET RETAIL REVENUE FOR Q1 2024 O'KEY Group S.A. reports a 7.2% YoY increase in net retail revenue for Q1 2024, driven by growth in all business segments. DA! discounters' revenue rose by 17.9% YoY Revenue Growth O'KEY Group S.A. Q1 2024 Net Retail Revenue DA! Discounters
BRIEF published on 04/22/2024 at 16:05, 7 months ago O'KEY Group Releases 2023 Annual Report and Financial Statements Financial Statements Annual Report IFRS O'KEY Group Russian Retailer
BRIEF published on 04/22/2024 at 16:05, 7 months ago O'KEY Group S.A. Announces 2024 Annual General Meeting Annual General Meeting Shareholders Financial Statements O'KEY Group S.A. Luxembourg
PRESS RELEASE published on 04/22/2024 at 16:00, 7 months ago O`KEY GROUP PUBLISHES ANNUAL REPORT FOR 2023 O`KEY Group S.A. (OKEY) publishes Annual Report for 2023 including consolidated financial statements prepared in accordance with IFRS. Details at https://okeygroup.lu/investors/annual-reports/ Consolidated Financial Statements Annual Report IFRS O'KEY Group S.A. Russia
PRESS RELEASE published on 04/22/2024 at 16:00, 7 months ago ANNUAL GENERAL MEETING OF THE SHAREHOLDERS OF THE COMPANY O'KEY Group S.A. announces the Annual General Meeting of Shareholders on May 21, 2024, to discuss financial statements and director compensation Annual General Meeting Shareholders Financial Statements O'KEY Group S.A. Director Compensation
BRIEF published on 04/19/2024 at 18:35, 7 months 3 days ago O'KEY Group Reports Financial Results for Fiscal Year 2023 EBITDA Revenue Growth Net Loss Financial Results 2023 O'KEY Group
PRESS RELEASE published on 04/19/2024 at 18:30, 7 months 3 days ago O`KEY GROUP REPORTS AUDITED FINANCIAL RESULTS FOR FY 2023 O'KEY Group S.A. (OKEY) reports audited financial results for FY 2023 including revenue growth and EBITDA performance. Details available on company's website Financial Results EBITDA FY 2023 O'KEY Group S.A. OKEY
Published on 11/22/2024 at 23:55, 9 hours 1 minute ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 26 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 9 hours 51 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 26 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 42 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 3 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 1 minute ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 16 hours 56 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 1 hour ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
